FATE Fate Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Sie 13, 2026
$2,32
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$0,9552tyg. minimum
$3,2352tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$271M
P/E (TTM)
-2.2
EPS (TTM)
$-1.05
Przychody (TTM)
$6M
Twoje odznaki
Zakres 52 tyg.
$1–$3
Ocena Analityków
HOLD
Cena Docelowa
$6
P/E
-2.2
ROE
-60.7%
Marża Zysku Netto
-1941.1%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
FATE Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$2.32
Kapitalizacja Rynkowa (MRQ)
$271M
P/E (TTM)
-2.2
EPS (TTM)
$-1.05
Przychody (TTM)
$6M
ROE (TTM)
-60.7%
Zakres 52 tyg.
$1–$3
FATE Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
O Fate Therapeutics, Inc. - Common Stock Przegląd firmy z Wikipedii
sektorHealthcare
branżaBiotechnology
pracownicy161
krajUS
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$7M2016-12-31 → 2025-12-31
EPS$-1.152020-12-31 → 2025-12-31
Wolny przepływ pieniężny$-112M2016-12-31 → 2025-12-31
Marża netto-1941.1%2018-12-31 → 2025-12-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | FATE | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | -2.2średnia z 5 lat ≈-6.7 | ≈-6.7 | · | · | |
| P/S (TTM) | 41.7średnia z 5 lat ≈29.4 | ≈29.4 | 48.5 | Wartość godziwa | |
| P/B (MRQ) | 1.8średnia z 5 lat ≈2.5 | ≈2.5 | 1.7 | Zawyżona wycena | |
| Cena / FCF (TTM) | -2.6średnia z 5 lat ≈-7.0 | ≈-7.0 | · | · | |
| Cena / Przepływy pieniężne (TTM) | -2.7średnia z 5 lat ≈-8.7 | ≈-8.7 | · | · | |
| Price / Tangible Book (Cena / Wartość księgowa materialna) | 1.3średnia z 5 lat ≈2.5 | ≈2.5 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | FATE | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża Operacyjna (TTM) | -2058.1%średnia z 5 lat ≈-954.7% | ≈-954.7% | -623.6% | Słaby | |
| Marża EBITDA (TTM) | -1873.4%średnia z 5 lat ≈-877.4% | ≈-877.4% | -619.0% | Słaby | |
| Marża Zysku Netto (TTM) | -1941.1%średnia z 5 lat ≈-868.7% | ≈-868.7% | -529.8% | Słaby | |
| ROA (TTM) | -39.9%średnia z 5 lat ≈-32.8% | ≈-32.8% | -35.2% | Zgodnie z | |
| ROE (TTM) | -60.7%średnia z 5 lat ≈-48.2% | ≈-48.2% | -45.1% | Słaby |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | FATE | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Wskaźnik bieżący (MRQ) | 4.8średnia z 5 lat ≈6.8 | ≈6.8 | 8.3 | Niska płynność | |
| Wskaźnik Szybkości (MRQ) | 4.7średnia z 5 lat ≈5.4 | ≈5.4 | 6.3 | Niska płynność |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | FATE | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | -51.2%średnia z 5 lat ≈-2.7% | ≈-2.7% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | -59.0%średnia z 5 lat ≈-23.4% | ≈-23.4% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | -26.7% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | FATE | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.0średnia z 5 lat ≈0.1 | ≈0.1 | 0.0 | Słaby | |
| Receivables Turnover (Rotacja należności) | 3.0średnia z 5 lat ≈4.6 | ≈4.6 | 3.6 | Słaby | |
| Revenue / Employee (Przychody / pracownika) | ≈$41.3K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
10.6%
Następny raport
Lis 11, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Sie 13, 2026 | $-0.25 | $-0.27 | 8.5% |
| 31 marca 2026 | Maj 11, 2026 | $-0.26 | $-0.29 | 9.0% |
| 31 grudnia 2025 | $-0.27 | $-0.28 | 1.9% | |
| 30 września 2025 | $-0.27 | $-0.30 | 9.1% | |
| 30 czerwca 2025 | $-0.29 | $-0.35 | 17.0% | |
| 31 marca 2025 | $-0.32 | $-0.39 | 18.1% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7M | $14M | $64M | $96M | $56M | $31M | $11M | $5M | $4M | $4M | $2M | · | |
| R&D Expense | $108M | $135M | $173M | $320M | $216M | $126M | $88M | $56M | $34M | $26M | $20M | $16M | |
| SG&A Expense | $47M | $74M | $81M | $84M | $57M | $34M | $24M | $16M | $12M | $10M | $10M | $8M | |
| Operating Expenses | $154M | $224M | $254M | $405M | $273M | $160M | $111M | $72M | $46M | $36M | $30M | $25M | |
| Operating Income | $-148M | $-210M | $-191M | $-308M | $-217M | $-128M | $-101M | $-67M | $-42M | $-32M | $-28M | $-25M | |
| Interest Expense | · | · | · | · | $0 | $0 | $2M | $2M | $1M | $2M | $2M | $549.0K | |
| Interest Income | $11M | $17M | $17M | $6M | $1M | $2M | $4M | $2M | $559.0K | $138.0K | $10.0K | $2.0K | |
| Other Non-op | $11M | $24M | $30M | $27M | $5M | $-45M | $3M | $494.0K | $-827.0K | $-1M | $-2M | $-979.0K | |
| Income Tax | $2.0K | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | |
| Net Income | $-136M | $-186M | $-161M | $-282M | $-212M | $-173M | $-98M | $-67M | $-43M | $-33M | $-30M | $-26M | |
| EPS (Basic) | $-1.15 | $-1.64 | $-1.64 | $-2.91 | $-2.24 | $-2.10 | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.15 | $-1.64 | $-1.64 | $-2.91 | $-2.24 | $-2.10 | · | · | · | · | · | · | |
| Shares (Basic) | 118,789,974 | 113,685,177 | 98,411,162 | 96,826,058 | 94,747,311 | 82,385,319 | · | · | · | · | · | · | |
| Shares (Diluted) | 118,789,974 | 113,685,177 | 98,411,162 | 96,826,058 | 94,747,311 | 82,385,319 | · | · | · | · | · | · | |
| EBITDA | $-135M | $-191M | $-172M | $-295M | $-211M | $-125M | $-99M | $-66M | $-41M | $-31M | $-27M | $-24M |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $47M | $36M | $42M | $61M | $134M | $167M | $100M | $191M | $89M | $89M | $65M | $49M | |
| Short-term Investments | $157M | $243M | $273M | $375M | $482M | · | · | · | · | $4M | · | · | |
| Receivables | $916.0K | $4M | $2M | $38M | $9M | $6M | · | $500.0K | · | · | · | · | |
| Prepaid Expense | $4M | $9M | $15M | $27M | $9M | $6M | $6M | $4M | $2M | $1M | $843.0K | $760.0K | |
| Current Assets | $209M | $292M | $332M | $502M | $633M | $494M | $227M | $205M | $103M | $93M | $66M | $50M | |
| PP&E (Net) | $57M | $64M | $97M | $110M | $92M | $32M | $11M | $5M | $3M | $2M | $2M | $1M | |
| PP&E (Gross) | $93M | $100M | $144M | $140M | $108M | $43M | $20M | $11M | $8M | $6M | $6M | $4M | |
| Accum. Depreciation | $36M | $35M | $48M | $30M | $17M | $11M | $9M | $6M | $5M | $4M | $3M | $3M | |
| Other Non-current Assets | $0 | $9.0K | $9.0K | $33.0K | $33.0K | $9.0K | $9.0K | $526.0K | $24.0K | $24.0K | $24.0K | $10.0K | |
| Total Assets | $319M | $441M | $506M | $706M | $921M | $622M | $302M | $213M | $105M | $95M | $68M | $51M | |
| Accounts Payable | $3M | $9M | $5M | $8M | $9M | $6M | $6M | $4M | $2M | $934.0K | $996.0K | $645.0K | |
| Accrued Liabilities | $20M | $21M | $28M | $54M | $42M | $16M | $15M | $11M | $7M | $4M | $2M | $2M | |
| Current Liabilities | $36M | $39M | $39M | $114M | $81M | $86M | $28M | $27M | $11M | $15M | $13M | $5M | |
| Capital Leases | $73M | $78M | $97M | $104M | $109M | $94M | $25M | · | · | · | · | · | |
| Long-term Debt | · | · | · | · | · | · | · | $18M | $19M | $13M | $22M | $20M | |
| Total Debt | · | · | · | · | · | · | · | $15M | $15M | $11M | $18M | $20M | |
| Common Stock | $115.0K | $114.0K | $99.0K | $97.0K | $96.0K | $88.0K | $76.0K | $65.0K | $53.0K | $41.0K | $29.0K | $21.0K | |
| Paid-in Capital | $1.74B | $1.72B | $1.58B | $1.54B | $1.45B | $941M | $628M | $446M | $296M | $249M | · | $141M | |
| Retained Earnings | $-1.53B | $-1.40B | $-1.21B | $-1.05B | $-769M | $-557M | $-384M | $-285M | $-219M | $-176M | $-142M | $-112M | |
| AOCI | $116.0K | $268.0K | $15.0K | $-2M | $-762.0K | $70.0K | $22.0K | $-2.0K | $-3.0K | $-1.0K | · | · | |
| Stockholders' Equity | $207M | $319M | $368M | $484M | $679M | $384M | $245M | $160M | $77M | $73M | $38M | $28M | |
| Liabilities + Equity | $319M | $441M | $506M | $706M | $921M | $622M | $302M | $213M | $105M | $95M | $68M | $51M | |
| Shares Outstanding | 115,359,735 | 113,928,279 | 98,627,076 | 97,294,917 | 95,726,962 | 87,722,237 | 75,730,260 | 64,693,681 | 52,648,601 | 41,386,506 | 28,716,570 | 20,569,399 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $13M | $19M | $18M | $14M | $6M | $3M | $2M | $1M | $971.0K | $881.0K | $687.0K | $496.0K | |
| Stock-based Comp | · | · | · | · | · | · | · | · | · | · | $2M | $2M | |
| Restructuring | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $17M | $44M | $10M | $20M | $43M | $131M | $13M | $27M | $5M | $3M | $9M | $534.0K | |
| Operating Cash Flow | $-106M | $-123M | $-132M | $-248M | $-163M | $-39M | $-83M | $-39M | $-37M | $-30M | $-18M | $-22M | |
| CapEx | $6M | $730.0K | $6M | $36M | $51M | $5M | $7M | $2M | $2M | $457.0K | $1M | $882.0K | |
| Investing Cash Flow | $111M | $12M | $113M | $167M | $-324M | $-161M | $-157M | $-463.0K | $-10M | $-4M | · | · | |
| Debt Issued | · | · | · | · | · | · | · | · | $15M | · | · | $20M | |
| Net Debt Issued | · | · | · | · | · | · | $-15M | · | $4M | $-8M | $-2M | $18M | |
| Stock Issued | · | · | · | · | $412M | $189M | $162M | $135M | $43M | · | $5M | $142.0K | |
| Net Stock Activity | · | · | · | · | $412M | $189M | $162M | · | · | · | $5M | $142.0K | |
| Financing Cash Flow | $5M | $100M | $85.0K | $9M | $453M | $283M | $150M | $141M | $47M | $58M | · | · | |
| Net Change in Cash | $11M | $-11M | $-20M | $-72M | $-34M | $83M | $-91M | $102M | $343.0K | $24M | $16M | $-5M | |
| Taxes Paid | $1.6K | $1.7K | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-112M | $-124M | $-138M | $-284M | $-214M | $-44M | $-91M | $-41M | $-39M | $-30M | $-20M | $-23M |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2222.4% | -1542.6% | -299.9% | -320.2% | -388.6% | -407.5% | -943.1% | -1415.4% | · | · | -1142.8% | · | |
| Net Margin | -2051.1% | -1366.5% | -253.3% | -292.6% | -379.9% | -551.6% | -919.0% | -1405.0% | · | · | -1233.7% | · | |
| EBITDA Margin | -2028.3% | -1403.5% | -271.1% | -305.9% | -378.1% | -397.7% | -922.6% | -1390.0% | · | · | -1114.6% | · | |
| ROA | -35.9% | -39.3% | -26.6% | -34.6% | -27.5% | -37.5% | -38.1% | -41.8% | -42.9% | -41.1% | -50.3% | -48.5% | |
| ROE | -58.2% | -54.7% | -41.7% | -56.2% | -30.1% | -42.9% | -38.3% | -39.8% | -69.9% | -60.2% | -90.4% | -65.4% |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.8 | 7.6 | 8.5 | 4.4 | 7.8 | 5.8 | 8.2 | 7.5 | 9.3 | 6.1 | 4.9 | 10.9 | |
| Quick Ratio | 5.7 | 7.3 | 8.1 | 4.2 | 1.8 | 2.0 | 3.6 | 7.0 | 8.1 | 6.1 | 4.8 | 10.7 | |
| Debt / Equity | · | · | · | · | · | · | · | 0.1 | 0.2 | 0.1 | 0.5 | 0.7 | |
| LT Debt / Equity | · | · | · | · | · | · | · | 0.1 | 0.2 | 0.0 | 0.3 | 0.6 | |
| Interest Coverage | · | · | · | · | · | · | -57.5 | -39.6 | -33.2 | -19.5 | -12.5 | -45.4 |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | · | · | 0.0 | · | |
| Receivables Turnover | 3.0 | 5.1 | 3.2 | 4.1 | 7.9 | 10.5 | · | 19.0 | · | · | · | · |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.80 | $2.80 | $3.74 | $4.97 | $7.09 | $4.38 | $3.23 | $2.48 | $1.47 | $1.77 | $1.32 | $1.38 | |
| Revenue / Share | $0.06 | $0.12 | $0.65 | $0.99 | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.89 | $-1.08 | $-1.34 | $-2.56 | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.40 | $0.32 | $0.42 | $0.63 | $1.40 | $1.91 | $1.32 | $2.94 | $1.69 | $2.14 | $2.26 | $2.39 | |
| EPS (TTM) | $-1.15 | $-1.64 | $-1.64 | $-2.91 | $-2.24 | $-2.10 | · | · | · | · | · | · |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -51.2% | -78.5% | -34.0% | 72.4% | 77.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -59.0% | -37.5% | 26.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -26.7% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $7M | $14M | $64M | $96M | $56M | $31M | $11M | $5M | $4M | $4M | $2M | $2M | |
| Net Income TTM | $-136M | $-186M | $-161M | $-282M | $-212M | $-173M | $-98M | $-67M | $-43M | $-33M | $-30M | $-26M | |
| Market Cap | $113M | $188M | $369M | $982M | $5.60B | $7.98B | $1.48B | $830M | $322M | $104M | $97M | $103M | |
| Enterprise Value | · | · | · | · | · | · | · | $654M | $248M | $22M | $50M | $74M | |
| P/E | -0.9 | -1.0 | -2.3 | -3.5 | -26.1 | -43.3 | · | · | · | · | · | · | |
| P/S | 17.0 | 13.8 | 5.8 | 10.2 | 100.3 | 253.8 | 138.8 | 175.1 | 78.3 | 23.6 | 39.8 | 64.1 | |
| P/B | 0.5 | 0.6 | 1.0 | 2.0 | 8.3 | 20.7 | 6.1 | 5.2 | 4.2 | 1.4 | 2.5 | 3.7 | |
| P / Tangible Book | 0.5 | 0.6 | 1.0 | 2.0 | 8.3 | 20.7 | · | · | · | · | · | · | |
| P / Cash Flow | -1.1 | -1.5 | -2.8 | -4.0 | -34.4 | -203.3 | -17.8 | -21.5 | -8.7 | -3.5 | -5.3 | -4.6 | |
| P / FCF | -1.0 | -1.5 | -2.7 | -3.5 | -26.2 | -180.6 | -16.4 | -20.3 | -8.3 | -3.4 | -4.9 | -4.4 | |
| EV / EBITDA | · | · | · | · | · | · | · | -9.9 | -6.0 | -0.7 | -1.9 | -3.0 | |
| EV / FCF | · | · | · | · | · | · | · | -16.0 | -6.4 | -0.7 | -2.5 | -3.2 | |
| EV / Revenue | · | · | · | · | · | · | · | 138.1 | 60.3 | 5.1 | 20.7 | 45.8 | |
| Earnings Yield | -117.3% | -99.4% | -43.9% | -28.8% | -3.8% | -2.3% | · | · | · | · | · | · |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $7M | $2M | $2M | $2M | $933.0K | $59M | $44M | $15M | |
| R&D Expense | $24M | $25M | $25M | $26M | $27M | $29M | $34M | $35M | $35M | $32M | $32M | $34M | $41M | $66M | $87M | $80M | |
| SG&A Expense | $9M | $10M | $11M | $11M | $11M | $14M | $15M | $21M | $17M | $21M | $18M | $19M | $23M | $22M | $22M | $22M | |
| Operating Expenses | $33M | $34M | $36M | $36M | $39M | $43M | $64M | $55M | $52M | $53M | $50M | $53M | $63M | $88M | $109M | $101M | |
| Operating Income | $-31M | $-33M | $-35M | $-35M | $-37M | $-41M | $-62M | $-52M | $-45M | $-51M | $-48M | $-51M | $-63M | $-29M | $-64M | $-86M | |
| Interest Income | $2M | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $5M | $4M | $4M | $5M | $4M | $4M | $3M | $2M | |
| Other Non-op | $975.0K | $2M | $2M | $2M | $3M | $4M | $10M | $5M | $7M | $3M | $4M | $6M | $10M | $10M | $8M | $3M | |
| Net Income | $-30M | $-31M | $-32M | $-32M | $-34M | $-38M | $-52M | $-48M | $-38M | $-48M | $-44M | $-45M | $-53M | $-19M | $-56M | $-84M | |
| EPS (Basic) | $-0.25 | $-0.26 | $-0.27 | $-0.27 | $-0.29 | $-0.32 | $-0.44 | $-0.40 | $-0.33 | $-0.47 | $-0.45 | $-0.46 | $-0.54 | $-0.19 | $-0.58 | $-0.86 | |
| EPS (Diluted) | $-0.25 | $-0.26 | $-0.27 | $-0.27 | $-0.29 | $-0.32 | $-0.44 | $-0.40 | $-0.33 | $-0.47 | $-0.45 | $-0.46 | $-0.54 | $-0.19 | $-0.58 | $-0.86 | |
| Shares (Basic) | 120,397,390 | 120,030,638 | · | 118,998,693 | 118,528,046 | 118,375,540 | · | 117,769,161 | 117,468,124 | 101,104,345 | · | 98,568,012 | 98,400,355 | 98,054,687 | · | 97,023,506 | |
| Shares (Diluted) | 120,397,390 | 120,030,638 | · | 118,998,693 | 118,528,046 | 118,375,540 | · | 117,769,161 | 117,468,124 | 101,104,345 | · | 98,568,012 | 98,400,355 | 98,054,687 | · | 97,023,506 | |
| EBITDA | $-31M | $-30M | · | $-35M | $-37M | $-38M | · | $-52M | $-45M | $-46M | · | $-51M | $-63M | $-24M | · | $-86M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $32M | $40M | $47M | $41M | $41M | $45M | $36M | $38M | $37M | $121M | $42M | $33M | $47M | $42M | $61M | $82M | |
| Short-term Investments | $121M | $135M | $157M | $175M | $182M | $196M | $243M | $259M | $268M | · | $273M | · | · | · | $375M | · | |
| Receivables | $703.0K | $704.0K | $916.0K | $682.0K | $1M | $2M | $4M | $4M | $1M | $858.0K | $2M | $2M | $3M | $14M | $38M | $10M | |
| Prepaid Expense | $3M | $4M | $4M | $5M | $6M | $5M | $9M | $9M | $13M | $10M | $15M | $13M | $11M | $15M | $27M | $20M | |
| Current Assets | $158M | $180M | $209M | $221M | $230M | $248M | $292M | $310M | $319M | $394M | $332M | $364M | $392M | $438M | $502M | $535M | |
| PP&E (Net) | $52M | $54M | $57M | $59M | $61M | $63M | $64M | $82M | $88M | $92M | $97M | $102M | $106M | $109M | $110M | $109M | |
| PP&E (Gross) | · | · | $93M | · | · | · | $100M | · | · | · | $144M | · | · | · | $140M | · | |
| Accum. Depreciation | · | · | $36M | · | · | · | $35M | · | · | · | $48M | · | · | · | $30M | · | |
| Other Non-current Assets | · | · | $0 | $0 | $0 | $0 | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $33.0K | $33.0K | $33.0K | $33.0K | |
| Total Assets | $260M | $285M | $319M | $344M | $372M | $399M | $441M | $495M | $529M | $570M | $506M | $544M | $585M | $630M | $706M | $749M | |
| Accounts Payable | $3M | $3M | $3M | $4M | $4M | $4M | $9M | $6M | $5M | $7M | $5M | $6M | $8M | $10M | $8M | $10M | |
| Accrued Liabilities | $15M | $14M | $20M | $18M | $18M | $17M | $21M | $24M | $23M | $32M | $28M | $29M | $29M | $32M | $54M | $50M | |
| Current Liabilities | $33M | $31M | $36M | $28M | $29M | $28M | $39M | $37M | $35M | $45M | $39M | $41M | $45M | $49M | $114M | $104M | |
| Capital Leases | $71M | $72M | $73M | $74M | $76M | $77M | $78M | $92M | $94M | $96M | $97M | $99M | $101M | $102M | $104M | $105M | |
| Common Stock | $117.0K | $116.0K | $115.0K | $115.0K | $115.0K | $115.0K | $114.0K | $114.0K | $114.0K | $114.0K | $99.0K | $99.0K | $99.0K | $98.0K | $97.0K | $97.0K | |
| Paid-in Capital | $1.75B | $1.75B | $1.74B | $1.74B | $1.73B | $1.72B | $1.72B | $1.71B | $1.70B | $1.69B | $1.58B | $1.57B | $1.56B | $1.55B | $1.54B | $1.52B | |
| Retained Earnings | $-1.60B | $-1.57B | $-1.53B | $-1.50B | $-1.47B | $-1.44B | $-1.40B | $-1.35B | $-1.30B | $-1.26B | $-1.21B | $-1.17B | $-1.12B | $-1.07B | $-1.05B | $-994M | |
| AOCI | $-117.0K | $-77.0K | $116.0K | $153.0K | $62.0K | $191.0K | $268.0K | $835.0K | $-422.0K | $-194.0K | $15.0K | $-499.0K | $-587.0K | $-646.0K | $-2M | $-3M | |
| Stockholders' Equity | $153M | $180M | $207M | $234M | $261M | $288M | $319M | $362M | $397M | $426M | $368M | $403M | $438M | $477M | $484M | $518M | |
| Liabilities + Equity | $260M | $285M | $319M | $344M | $372M | $399M | $441M | $495M | $529M | $570M | $506M | $544M | $585M | $630M | $706M | $749M | |
| Shares Outstanding | 116,694,106 | 116,272,513 | 115,359,735 | 115,336,697 | 114,655,067 | 114,603,910 | 113,928,279 | 113,884,884 | 113,849,557 | 113,798,942 | 98,627,076 | 98,585,750 | 98,522,718 | 98,191,015 | 97,294,917 | 97,112,209 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $3M | $3M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $5M | $3M | |
| Restructuring | · | · | · | $1M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-3M | · | · | · | $479.0K | · | · | · | $10M | · | · | · | $-14M | · | · | |
| Operating Cash Flow | $-23M | $-31M | $-23M | $-24M | $-25M | $-34M | $-28M | $-29M | $-32M | $-33M | $-37M | $-38M | $-28M | $-29M | $-75M | $-55M | |
| CapEx | $80.0K | $239.0K | $1M | $2M | $1M | $1M | $98.0K | $495.0K | $51.0K | $86.0K | $181.0K | $565.0K | $2M | $3M | $7M | $9M | |
| Investing Cash Flow | $15M | $24M | $28M | $21M | $20M | $43M | $23M | $25M | $-53M | $17M | $45M | $25M | $33M | $9M | $53M | $80M | |
| Stock Issued | · | · | · | · | · | · | · | · | $-104.0K | $75M | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $-104.0K | $75M | · | · | · | · | · | · | |
| Financing Cash Flow | · | · | $2M | $2M | $1M | $0 | $3M | $0 | $1M | $95M | $-180.0K | $0 | $58.0K | $207.0K | $2M | $1M | |
| Net Change in Cash | $-7M | $-7M | $6M | $-627.0K | $-4M | $9M | $-2M | $-4M | $-84M | $79M | $9M | $-13M | $5M | $-19M | $-21M | $27M | |
| Free Cash Flow | · | $-31M | · | · | · | $-35M | · | · | · | $-33M | · | · | · | $-32M | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1495.4% | -2540.4% | · | -1995.1% | -1938.5% | -2534.1% | · | -1703.9% | -665.7% | -2652.9% | · | -2637.8% | -6705.8% | -48.5% | · | -576.7% | |
| Net Margin | -1448.6% | -2402.8% | · | -1852.4% | -1786.6% | -2309.4% | · | -1551.0% | -567.4% | -2493.7% | · | -2323.6% | -5654.3% | -32.0% | · | -557.8% | |
| EBITDA Margin | -1495.4% | -2315.8% | · | -1995.1% | -1938.5% | -2329.5% | · | -1703.9% | -665.7% | -2402.4% | · | -2637.8% | -6705.8% | -41.4% | · | -576.7% | |
| ROA | -9.6% | -9.1% | · | -7.7% | -7.6% | -7.8% | · | -9.2% | -6.9% | -8.0% | · | -7.0% | -7.6% | -2.5% | · | -9.6% | |
| ROE | -14.5% | -13.3% | · | -10.8% | -10.3% | -10.5% | · | -12.5% | -9.2% | -10.6% | · | -9.8% | -10.4% | -3.4% | · | -13.4% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.8 | 5.8 | · | 7.9 | 8.0 | 8.8 | · | 8.3 | 9.2 | 8.7 | · | 8.8 | 8.8 | 9.0 | · | 5.2 | |
| Quick Ratio | 4.7 | 5.7 | · | 7.7 | 7.8 | 8.6 | · | 8.0 | 8.8 | 2.7 | · | 0.8 | 1.1 | 1.1 | · | 0.9 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | |
| Receivables Turnover | 2.0 | 0.8 | · | 0.7 | 1.6 | 1.0 | · | 1.1 | 3.5 | 0.3 | · | 0.3 | 0.1 | 4.3 | · | 1.7 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.31 | $1.55 | · | $2.03 | $2.28 | $2.52 | · | $3.18 | $3.49 | $3.74 | · | $4.09 | $4.44 | $4.86 | · | $5.33 | |
| Revenue / Share | $0.02 | $0.01 | · | $0.01 | $0.02 | $0.01 | · | $0.03 | $0.06 | $0.02 | · | $0.02 | $0.01 | $0.60 | · | $0.15 | |
| Cash Flow / Share | $-0.19 | $-0.26 | · | · | · | $-0.29 | · | · | · | $-0.33 | · | · | · | $-0.29 | · | · | |
| Cash / Share | $0.28 | $0.34 | · | $0.35 | $0.36 | $0.39 | · | $0.33 | $0.32 | $1.07 | · | $0.34 | $0.47 | $0.43 | · | $0.85 | |
| EPS (TTM) | $-1.05 | $-1.09 | · | $-1.32 | $-1.45 | $-1.49 | · | $-1.65 | $-1.71 | $-1.92 | · | $-1.77 | $-2.17 | $-2.42 | · | $-3.05 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6M | $6M | · | $7M | $8M | $13M | · | $13M | $12M | $6M | · | $106M | $119M | $137M | · | $69M | |
| Net Income TTM | $-126M | $-130M | · | $-156M | $-172M | $-176M | · | $-178M | $-176M | $-190M | · | $-173M | $-212M | $-235M | · | $-294M | |
| Market Cap | $315M | $140M | · | $145M | $128M | $91M | · | $399M | $373M | $835M | · | $209M | $469M | $560M | · | $2.18B | |
| P/E | -2.6 | -1.1 | · | -1.0 | -0.8 | -0.5 | · | -2.1 | -1.9 | -3.8 | · | -1.2 | -2.2 | -2.4 | · | -7.3 | |
| P/S | 48.5 | 22.1 | · | 20.4 | 15.2 | 6.8 | · | 29.6 | 30.3 | 128.9 | · | 2.0 | 3.9 | 4.1 | · | 31.5 | |
| P/B | 2.1 | 0.8 | · | 0.6 | 0.5 | 0.3 | · | 1.1 | 0.9 | 2.0 | · | 0.5 | 1.1 | 1.2 | · | 4.2 | |
| P / Tangible Book | 2.1 | 0.8 | · | 0.6 | 0.5 | 0.3 | · | 1.1 | 0.9 | 2.0 | · | 0.5 | 1.1 | 1.2 | · | 4.2 | |
| P / Cash Flow | -13.5 | -4.5 | · | · | · | -2.7 | · | · | · | -25.0 | · | · | · | -19.4 | · | · | |
| Earnings Yield | -38.9% | -90.8% | · | -104.8% | -129.5% | -188.6% | · | -47.1% | -52.1% | -26.2% | · | -83.5% | -45.6% | -42.5% | · | -13.6% |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $7M | $14M | $64M | $96M | $56M |
| Marża Operacyjna % | -2222.4% | -1542.6% | -299.9% | -320.2% | -388.6% |
| Zysk netto | $-136M | $-186M | $-161M | $-282M | $-212M |
| Rozwodniony EPS | $-1.15 | $-1.64 | $-1.64 | $-2.91 | $-2.24 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 5.8 | 7.6 | 8.5 | 4.4 | 7.8 |
| Wskaźnik Szybkości | 5.7 | 7.3 | 8.1 | 4.2 | 1.8 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-112M | $-124M | $-138M | $-284M | $-214M |
Właściciele instytucjonalni (13F) 166 emitentów · $189.3M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
166
Wartość posiadanych akcji
$189.3M
Nowe pozycje
33
Zamknięte pozycje
30
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 33 (+2 vs poprzedni kw.) | 30 (+16 vs poprzedni kw.) | 60 (+5 vs poprzedni kw.) | 36 (+2 vs poprzedni kw.) | -1.9M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| Redmile Group, LLC | $34 756 954 | 12 872 946 | 18,36% | Akcje |
| BlackRock, Inc. | $19 707 016 | 7 298 895 | 10,41% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12 273 911 | 4 545 893 | 6,48% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $12 002 947 | 4 445 536 | 6,34% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $10 360 518 | 3 837 229 | 5,47% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $9 692 630 | 3 589 863 | 5,12% | Akcje |
| JOHNSON & JOHNSON | $9 123 473 | 3 379 064 | 4,82% | Akcje |
| VANGUARD GROUP INC | $8 818 834 | 8 971 347 | 4,66% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $8 054 824 | 2 983 268 | 4,25% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $6 571 741 | 2 433 978 | 3,47% | Akcje |
| GOLDMAN SACHS GROUP INC | $5 532 805 | 2 049 187 | 2,92% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $3 571 058 | 1 322 013 | 1,89% | Akcje |
| JANE STREET GROUP, LLC | $2 772 919 | 1 027 007 | 1,46% | Akcje |
| CITADEL ADVISORS LLC | $2 681 931 | 993 308 | 1,42% | Akcje |
| Bruce & Co., Inc. | $2 670 808 | 989 188 | 1,41% | Akcje |
| MORGAN STANLEY | $1 875 366 | 694 580 | 0,99% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $1 729 156 | 640 428 | 0,91% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1 649 562 | 610 949 | 0,87% | Akcje |
| TWO SIGMA ADVISERS, LP | $1 622 960 | 1 651 700 | 0,86% | Akcje |
| UBS Group AG | $1 593 481 | 590 178 | 0,84% | Akcje |
| Qube Research & Technologies Ltd | $1 561 005 | 578 150 | 0,82% | Akcje |
| Connor, Clark & Lunn Investment Management Ltd. | $1 552 487 | 574 995 | 0,82% | Akcje |
| STATE STREET CORP | $1 509 106 | 558 928 | 0,80% | Akcje |
| DAFNA Capital Management LLC | $1 417 500 | 525 000 | 0,75% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 379 835 | 511 050 | 0,73% | Akcje |
| MARSHALL WACE, LLP | $1 329 551 | 492 426 | 0,70% | Akcje |
| IEQ CAPITAL, LLC | $1 316 866 | 487 728 | 0,70% | Akcje |
| Point72 Asset Management, L.P. | $1 194 016 | 442 228 | 0,63% | Akcje |
| Privium Fund Management B.V. | $1 118 640 | 414 311 | 0,59% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $949 091 | 352 226 | 0,50% | Akcje |
| Susquehanna Portfolio Strategies, LLC | $912 757 | 338 058 | 0,48% | Akcje |
| Cerity Partners LLC | $854 028 | 341 732 | 0,45% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $733 412 | 271 634 | 0,39% | Akcje |
| Invesco Ltd. | $718 151 | 265 982 | 0,38% | Akcje |
| Headlands Technologies LLC | $679 865 | 251 802 | 0,36% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $663 697 | 245 814 | 0,35% | Akcje |
| NORTHERN TRUST CORP | $655 212 | 242 671 | 0,35% | Akcje |
| HSBC HOLDINGS PLC | $635 511 | 240 724 | 0,34% | Akcje |
| LPL Financial LLC | $550 114 | 203 746 | 0,29% | Akcje |
| Mariner, LLC | $518 762 | 192 215 | 0,27% | Akcje |
| BARCLAYS PLC | $507 571 | 187 989 | 0,27% | Akcje |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $499 500 | 185 000 | 0,26% | Akcje |
| XTX Topco Ltd | $488 230 | 180 826 | 0,26% | Akcje |
| Aster Capital Management (DIFC) Ltd | $476 820 | 176 600 | 0,25% | Akcje |
| Man Group plc | $475 489 | 176 107 | 0,25% | Akcje |
| Woodline Partners LP | $431 055 | 159 650 | 0,23% | Akcje |
| BANK OF AMERICA CORP /DE/ | $415 006 | 153 706 | 0,22% | Akcje |
| Squarepoint Ops LLC | $414 785 | 153 624 | 0,22% | Akcje |
| Arete Wealth Advisors, LLC | $405 000 | 150 000 | 0,21% | Akcje |
| Assenagon Asset Management S.A. | $393 763 | 145 838 | 0,21% | Akcje |
Aktywiści i właściciele 5%+ 4 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Redmile Group, LLC, Jeremy C. Green, RedCo II Offshore SPV LLC, RedCo II Master Fund, L.P. ×11 zgłoszenia | 22 kwietnia 2026 | 14,90% | Aneks | · | SEC |
| Polaris Venture Partners V, L.P. (“PVP V”), Polaris Venture Partners Entrepreneurs’ Fund V, L.P. (“PVPE V”), Polaris Venture Partners Founders’ Fund V, L.P. (“PVPFF V”), Polaris Venture Partners Special Founders’ Fund V, L.P. (“PVPSFF V”), Polaris Venture Management Co. V, L.L.C. (“PVM V”), Jonathan A. Flint (“Flint”), Terrance G. McGuire (“McGuire”), Amir Nashat (“Nashat”) ×2 zgłoszenia | 21 grudnia 2018 | · | Pierwotne zgłoszenie | · | SEC |
| 5 grudnia 2016 | · | Pierwotne zgłoszenie | · | SEC | |
| ARCH Venture Fund VI, L.P., ARCH Venture Partners VI, L.P., ARCH Venture Partners VI, LLC, Clinton Bybee, Keith Crandell, Robert Nelsen ×3 zgłoszenia | 15 sierpnia 2016 | · | Pierwotne zgłoszenie | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 30 insiderów · 13 dyrektorzy generalni · 17 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Scott J Wolchko | President and CEO | 1 lutego 2024 A | 371 248 | 0 | 0 | $0 |
| Christian Weyer | President and Chief Executive Officer | 13 kwietnia 2015 M | 30 429 | 0 | 0 | $0 |
| Kamal Adawi | Chief Financial Officer | 15 stycznia 2026 A | 100 000 | 0 | 0 | $0 |
| Edward J Dulac III | Chief Financial Officer | 4 marca 2024 S | 101 479 | 0 | 0 | $0 |
| Jerome Charles Bressi | Chief Regulatory and Quality Officer | 15 stycznia 2025 A | 335 203 | 0 | 0 | $0 |
| Brian T. Powl | Chief Commercial Officer | 5 lipca 2023 S | 41 146 | 0 | 0 | $0 |
| Yu-Waye Chu | Chief Medical Officer | 18 kwietnia 2023 S | 140 676 | 0 | 0 | $0 |
| Mark Plavsic | Chief Technical Officer | 10 stycznia 2023 S | 123 705 | 0 | 0 | $0 |
| Daniel D Shoemaker | Chief Scientific Officer | 8 marca 2021 S | 73 020 | 0 | 0 | $0 |
| Stewart Abbot | Chief Development Officer | 15 maja 2018 M | 64 917 | 0 | 0 | $0 |
| Chris Storgard | Chief Medical Officer | 16 stycznia 2018 A | 37 593 | 0 | 0 | $0 |
| Peter D Flynn | Senior Vice President, Early Program Development | 5 stycznia 2015 A | 6 505 | 0 | 0 | $0 |
| Pratik S Multani | Chief Medical Officer | 5 stycznia 2015 A | 3 024 | 0 | 0 | $0 |
| Yuan Xu | Dyrektor | 12 czerwca 2026 A | 8 669 | 0 | 0 | $0 |
| Karin Jooss | Dyrektor | 12 czerwca 2026 A | 9 848 | 0 | 0 | $0 |
| Laura Hamill | Dyrektor | 12 czerwca 2026 A | · | 0 | 0 | $0 |
| Michael Stewart Lee | Dyrektor | 12 czerwca 2026 A | 11 331 | 0 | 0 | $0 |
| Shefali Agarwal | Dyrektor | 12 czerwca 2026 A | 10 490 | 0 | 0 | $0 |
| Matt Abernethy | Dyrektor | 12 czerwca 2026 A | · | 0 | 0 | $0 |
| Robert S Epstein | Dyrektor | 12 czerwca 2026 A | 36 331 | 0 | 0 | $0 |
| William H Rastetter | Dyrektor | 12 czerwca 2026 A | 36 331 | 0 | 0 | $0 |
| Neelufar Mozaffarian | Dyrektor | 29 maja 2025 A | · | 0 | 0 | $0 |
| John Mendlein | Dyrektor | 29 maja 2025 A | 311 231 | 0 | 0 | $0 |
| Timothy Coughlin | Dyrektor | 7 czerwca 2024 A | 9 892 | 0 | 0 | $0 |
| Robert Hershberg | Dyrektor | 6 czerwca 2023 A | 10 659 | 0 | 0 | $0 |
| Amir Nashat | Dyrektor | 1 sierpnia 2019 S | 11 034 | 0 | 0 | $0 |
| Mark J Enyedy | Dyrektor | 11 maja 2016 A | · | 0 | 0 | $0 |
| Robert Nelsen | Dyrektor | 4 października 2013 C | 2 473 188 | 0 | 0 | $0 |
| Bahram Valamehr | · | 4 sierpnia 2026 S | 591 815 | 0 | 3 | $-168 081 |
| Cindy Tahl | · | 4 sierpnia 2026 S | 589 355 | 0 | 3 | $-154 781 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 8 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,51% | 50 199 SH | 1 października 2026 | Dziennie |
| IWC · iShares Trust | 0,06% | 387 392 SH | 11 września 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 228 436 SH | 29 września 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,00% | 15 790 NS | 31 lipca 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 6 246 NS | 31 lipca 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 1 149 276 SH | 19 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3 194 411 SH | 19 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,00% | 272 591 SH | 19 sierpnia 2026 | Dziennie |
FATE Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 18 analityków
KUP
Średni cel
$7.00
+201,7%
5 27,8%
Mocne kupno
6 33,3%
Kup
7 38,9%
Trzymaj
0 0,0%
Sprzedaj
0 0,0%
Mocna sprzedaż
12-miesięczny cel cenowy
9 analityków · 2026-10-01Średnia cel $5.74 +147,6%
Teraz
Aktualna cena $2.32
Niski$2.20
Średnia$5.74
Wysoki$8.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| FATE | $113M | -0.9 | -51.2% | -2051.1% | -58.2% | · |
| VNDA | $521M | -2.4 | 8.7% | -102.0% | -54.2% | · |
| RCKT | · | · | · | · | · | · |
| ZSQR | · | · | · | · | · | · |
| IPSC | $87M | -7.1 | 1556.8% | -8.8% | -5.2% | · |
| UPB | $1.47B | -10.2 | 20.4% | -5026.0% | -38.3% | · |
| SABS | · | · | · | · | · | · |
| IKT | $270M | -4.2 | 111.0% | -1299.0% | -38.2% | · |
| TLSI | · | · | · | · | · | · |
| IMRX | · | -5.2 | · | · | -45.3% | · |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Sie 13, 2026